Posts Tagged ‘CCHR’

Can Prozac Cause Kids to Kill? A Canadian Judge Has Ruled it Can

Wednesday, December 7th, 2011

Note from CCHR:

(see videos at the bottom of this post from film maker Michael Moore and Fox National News reporter Douglas Kennedy)

It is well documented that psychiatric drugs, particularly antidepressants, can cause a host of violent side effects including mania, psychosis, aggression, violence and in the case of the antidepressant Effexor, homicidal ideation.   As far back as 1991, CCHR helped organize dozens of individuals and experts testifying before the US FDA that people with no prior history of violence (or suicide) became homicidal and suicidal under the influence of antidepressants (see CCHR’s exclusive footage of the 1991 hearings here).  It would take the FDA another 13 years to admit antidepressants could cause suicide and black box warnings were finally issued in 2004.  However, despite all the documented violence-inducing side effects of these drugs, the FDA has never issued black box warnings on antidepressants causing violence or homicide despite the fact that at least 11 recent school shootings were committed by kids documented to be on or in withdrawal from psychiatric drugs (see Fox News special report on school shootings here).   Therefore, the case cited below, where a Canadian judge ruled that a teenage boy murdered his friend due to being on the antidepressant Prozac, and the fact that the case will not be appealed, is a major turning point in exposing the violence inducing effects of antidepressant drugs.  

National Post
By Tom Blackwell
December 7, 2011

JB Reed/Bloomberg News

A Winnipeg judge’s ruling that a teenage boy murdered his friend because of the effects of Prozac will not be appealed, confirming an apparent North American first and reviving debate around the widespread prescription of anti-depressants to young people.

Justice Robert Heinrichs concluded the 15-year-old boy was under the influence of the medication when he thrust a nine-inch kitchen knife into the chest of Seth Ottenbreit, a close friend.

Although the killer pleaded guilty to second-degree murder, the judge cited the drug’s alleged side effects as a reason not to raise the case to adult court, and to mete out a sentence last month of just 10 months – on top of two years already spent in jail.

A spokeswoman for the Manitoba Justice Department said this week prosecutors have decided not to appeal the provincial-court decisions, which were earlier met with outrage from Mr. Ottenbreit’s family and friends.

Both the boy’s lawyer and the psychiatrist who testified on his behalf say it is the first time a criminal-court judge in North America has made such a finding.

Prozac is meant to curb the effects of depression, but Justice Heinrich concluded it set off a steady deterioration in the young murderer’s behaviour.

“He had become irritable, restless, agitated, aggressive and unclear in his thinking,” the judge said. “It was while in that state he overreacted in an impulsive, explosive and violent way. Now that his body and mind are free and clear of any effects of Prozac, he is simply not the same youth in behaviour or character.”

Yet the empirical underpinning of his conclusion, and the pros and cons of young people taking Prozac and other “selective serotonin reuptake inhibitor (SSRI)” anti-depressants, seem less clear-cut.

Justice Heinrichs relied largely on the expert testimony of Dr. Peter Breggin, a controversial American physician known for his outspoken opposition to the use of virtually any psychiatric drug. Some other experts say scientific evidence of a link between the latest anti-depressants and homicide is thin.

“I think it got pulled out of a hat, frankly,” said Dr. Umesh Jain, a child and adolescent psychiatrist at Toronto’s Centre for Addiction and Mental health. “You could construct a weak and biologically plausible effect, but you’d have to be pretty convincing in court.”

Studies have established such drugs can increase the risk of young patients having suicidal thoughts. Their tendency to lift inhibition could also release some hostility or violence lurking in a person’s character, said Dr. Jain. Small studies like one he co-authored in 1992 have also suggested that the drugs can trigger short-term mania, especially in bi-polar disorder patients.

There is little or no scientific evidence directly linking the anti-depressants and serious violence or homicide, though, he said.

Still, the official “product monograph” approved by Health Canada for Prozac says the drugs are not recommended for use on adolescents, and warns that agitation, hostility and aggression might ensue. Doctors are allowed to prescribe medications “off label” to patients even when the approval does not expressly permit it.

Specialists in Winnipeg responded to concerns voiced by the accused’s parents by actually increasing the dose, said Greg Brodsky, the teenager’s lawyer.

“On Prozac he was becoming more irrational and aggressive,” Mr. Brodsky said. “That should have been a warning. That warning wasn’t heeded.”

SSRI drugs have a contentious track record. They were hailed originally as a safe alternative to older anti-depressants, then clinical-trial results came to light in 2004 that suggested they increased the risk of children and adolescents having suicidal thoughts.

Other studies have indicated they are effective in patients with major depression, but little better than a placebo for mild to moderate cases.

The Winnipeg murderer had a history of smoking marijuana, had abused prescription drugs and “experimented” with cocaine, but was trying to break free of that background when a family doctor prescribed Prozac for depression in July, 2009.

On Sept. 20, the accused met with Mr. Ottenbreit and another friend at his house, after the two friends had earlier stormed into his home, allegedly damaging the floor. The killer and Mr. Ottenbreit shared a cigarette, before the accused pulled aside a sweater on the floor of his garage, revealing the knife. He picked it up, “got this weird look on his face,” then abruptly stabbed his friend, the other boy told police.

“They were in my house, they dented the floor, I had nothing else to do but to stab him,” he told police later.

Dr. Keith Hildahl, clinical head of Winnipeg’s Child and Adolescent Mental Health program, testified that the Prozac might have played a role, but concluded on balance that his behaviour that summer was largely a result of the tense relationship he had with his parents.

Dr. Breggin, who has testified in a number of U.S. cases where anti-depressants allegedly led to murder or other violence and reviewed the Winnipeg case, pointed the finger of blame at the medication.

“These drugs produce a stimulant or activation continuum,” he said in an interview. “That continuum includes aggression, hostility, loss of impulse control … all of which are a prescription for violence.”

Dr. Breggin’s long-standing criticism of psychiatric drugs and opposition to the view that psychiatric problems have biochemical roots have prompted some supporters to call him the “conscience” of the speciality, and some psychiatrists and patient advocates to condemn him as a harmful influence.

Read article here:  http://news.nationalpost.com/2011/12/07/prozac-defence-stands-in-manitoba-teens-murder-case/

See Michael Moore discuss the need for an investigation into psychiatric drugs causing violence:

See Fox National News on School Shootings and Psychiatric Drugs:

To read international warnings and studies on psychiatric drugs causing violence – visit CCHRInt’s Psychiatric Drug database and simply type in keywords such as violence, mania, psychosis, aggression in the red search box

« Return to news items


Share

Big Pharma’s Scam: U.S. Drug companies rig medication studies

Tuesday, December 6th, 2011

December 6, 2011  – Note from CCHR:  We created the psychiatric drug side effects database due to the misleading studies about psychiatric drug safety and efficacy being put out by the psychiatric/pharmaceutical industry.  For facts (instead of pharma funded studies)  from international drug regulatory agencies visit the psychiatric drug side effects database – click here

Many of these pharmaceutical studies were sponsored by the drug manufacturers; sponsors who the report states "may promote the use of outcomes that are most likely to indicate favourable results for their products."

Mercola.com—New research has revealed just how misleading and questionable the results of medication studies cited in top medical journals actually are — adding to an already sizeable mountain of data on mainstream medical manipulation.

Pharmaceutical and vaccine makers are continually found to be sponsoring the very institution performing the study on the effectiveness of their product.

Such is the case with a recent inquiry that examined the trustworthiness of top drug trials.

Investigators from UCLA and Harvard recently analyzed the randomized drug trials from six prestigious journals, reaching a conclusion that brings into question the overall credibility of many top medication studies and those who perform them.

  •  Many medication studies published in leading journals have been found to be sponsored by drug manufacturers and include deceptive statistical reporting and wording.

 

  • The flu vaccine is a perfect example of medical manipulation, with research concluding the effectiveness of the shots to be as low as one percent. In addition, the “gold standard” for scientific reviews has repeatedly found that there is little to no evidence backing flu vaccines as an effective flu prevention strategy. Despite this, they are still pushed by mainstream health officials
  • The reason why much of the population believes in mainstream medicine can be traced back to the PR campaigns of Edward Bernays, the so-called father of spin. Bernays focused on ‘conditioning’ consumers into believing many mainstream medical fallacies.

The investigative team found that many of these pharmaceutical studies were sponsored by the drug manufacturers; sponsors who the report states “may promote the use of outcomes that are most likely to indicate favourable results for their products.”

In fact many of these studies have been found to utilize different statistical techniques in order to establish the supposed safety of many medications that may actually be harmful to you.

———————————————————————–

For international drug regulatory warnings on documented side effects/risks of psychiatric drugs click here

 

« Return to news items


Share

Is the American Psychiatric Association in Bed with Big Pharma? Answer: Yes

Tuesday, November 29th, 2011

Note from CCHR Int:  We’re happy to see more and more press running stories containing the facts about psychiatric diagnoses, that mental disorders are not diseases on par with real medical diseases as the psychiatric/pharmaceutical marketing teams would have you believe, but lists of behaviors and emotions repackaged as disease in order to sell billions of dollars worth of pharmaceutical ‘solutions.’   CCHR was the first organization to point out that psychiatric disorders were not medical conditions discovered in labs, but disorders invented in committee by pharmaceutically funded psychiatrists.  We’re very pleased we’re no longer the only ones reporting the facts about psychiatry and its marketing campaigns.  Get the facts here

Do we really need more mental disorder diagnoses creating the need for more drugs in a society that some would say is already over-medicated?

The Fog City Journal – 11/29/2011
by Ralph E. Stone

“The critics — and the public too — have a stake in the proposed DSM-V. More mental disorders may mean just more drugs in our over-medicated society.”

The Diagnostic and Statistical Manual of Mental Disorders (DSM) is published by the American Psychiatric Association. The DSM provides a common language and standard criteria for the classification of mental disorders, which is used in the United States and to some extent internationally, by clinicians, researchers, psychiatric drug regulation agencies, health insurance companies, pharmaceutical companies, and policy makers. The DSM is produced by a panel of psychiatrists, many of whom have financial ties to the pharmaceutical industry. It is considered the “bible” of American psychiatry. The latest edition — DSM-IV — was published in 1994.

In 1952, the DSM was a small, spiral-bound handbook (DSM-I), but the latest edition (DSM-IV), is a 943-page magnum opus. Over time, psychiatric diagnoses have increased in the American population and in turn, drugs that affect mental states are then used to treat them. The theory that psychiatric conditions are caused by a biochemical imbalance is often used as a justification for their widespread use, even though the theory in unproven. Since there are no objective tests for mental illness and what is normal and abnormal is often unclear, psychiatry is a particularly fertile field for creating new diagnoses or broadening old ones.

Medications are widely used to treat the symptoms of mental disorders such as schizophrenia, depression, bipolar disorder, anxiety disorders, and attention deficit-hyperactivity disorder. Sometimes medications are used with other treatments such as psychotherapy.

While I am sure research in mental disorders account for some of this increase, I cannot help but believe that there is a certain amount of disease-peddling going on. That is, instead of promoting drugs to treat diseases, diseases are promoted to fit the drugs. For example, shyness as a psychiatric illness made its debut as “social phobia” in DSM-III in 1980, but was said to be rare. By 1994, when DSM-IV was published, it had become “social anxiety disorder,” now said to be extremely common, thus, boosting sales of antidepressants. Now, social anxiety disorder is “a severe medical condition.” In 1999, the FDA approved a drug for social anxiety disorder. After a successful marketing campaign, the sales of Paxil soared.

Presently, a revised version of the DSM is set for publication in 2013. The proposed revision has proven quite controversial. A group of psychologists with the Society for Humanistic Psychology, for examle, has filed a petition objecting to many of the revisions, arguing that they broaden the definition of mental health disorders, which, in turn, could lead to over treatment with drugs. Some, but not all, of the objections of the Society — along with the British Psychological Society and the American Counseling Association — to the proposed DSM-V include:

- The proposed DSM “fails to explicitly state that deviant behavior and primary conflicts between the individual and society are not mental disorders. Given lack of consensus as to the ‘primary’ causes of mental distress, this proposed change may result in the labeling of sociopolitical deviance as mental disorder.”

- “Several new proposals with little empirical basis also warrant hesitation: For example, ‘Apathy Syndrome,’ ‘Internet Addiction Disorder,’ and ‘Parental Alienation Syndrome’ have virtually no basis in the empirical literature.”

- “…clients and the general public are negatively affected by the continued and continuous medicalization of their natural and normal responses to their experiences; responses which undoubtedly have distressing consequences which demand helping responses, but which do not reflect illnesses so much as normal individual variation.”

Do we really need more mental disorder diagnoses creating the need for more drugs in a society that some would say is already over-medicated? Let’s look at some statistics. According to the Centers for Disease Control and Prevention (CDC) the percentage of Americans who took at least one prescription drug in the past month increased from 44 percent to 48 percent over the past ten years. The use of two or more drugs increased from 25 percent to 31 percent. The use of five or more drugs increased from 6 percent to 11 percent. And in 2007-2008, 1 out of every 5 children and 9 out of 10 older Americans reported using at least one prescription drug in the past month.

And Americans are spending more on drugs. According to the CDC, spending for prescription drugs in the U.S. was $234.1 billion in 2008, which was more than double what was spent in 1999.

And the pharmaceutical industry is profiting. According to Fortune 500 (May 3, 2010 issue date), the profits for the twelve largest pharmaceutical companies was almost $64 billion in 2010. Clearly, Pharma has a financial interest in a DSM with more mental disorders because it will mean a demand for more drugs to treat them.

The critics — and the public too — have a stake in the proposed DSM-V. More mental disorders may mean just more drugs in our over-medicated society.

Supreme Court Justice Oliver Wendell Holmes once quipped, “If all the drugs were thrown in the ocean, everyone would be better-off . . . except for the fish.” While this is a an overstatement, it does contain a grain of truth.

http://www.fogcityjournal.com/wordpress/3217/is-the-american-psychiatric-association-in-bed-with-big-pharma/

« Return to news items


Share

NY Times—Payments to Doctors by Pharma Raise Issues of Conflicts, CCHR warns of tainted mental health policies

Friday, November 25th, 2011

New York Times November 24, 2011

The financial relationships raise questions about the influence of drug companies on prescribing patterns or research results. The practice “puts patients and tax dollars at risk,” said Lee Spiller, the policy director for the Texas branch of the Citizens Commission on Human Rights,  a nonprofit mental health watchdog. “It taints the whole process. I’d hate to think donations were shaping state mental health policy in particular.”

State records show that of the 74 doctors and psychiatrists statewide who have routinely prescribed the highest number of costly antipsychotic drugs to patients on Medicaid, the joint state-federal health insurance program for the disabled, children and the very poor, 10 received payments from drug companies in 2009-11 — from $11,000 to $180,000 each.

By EMILY RAMSHAW and RYAN MURPHY
Published: November 24, 2011

Thousands of Texas doctors, researchers and medical experts — including more than 100 who are employed by the state and are paid with taxpayer dollars — routinely supplement their salaries with income from pharmaceutical companies.

Drug companies pay medical professionals for a wide range of activities, from speaking engagements to consulting. While legal, the practice raises questions about potential conflicts, and whether the interests of patients may be compromised.

From 2009 to early 2011, at least 25,000 Texas physicians and researchers received a combined $57 million — and probably far more — in cash payments, research money, free meals, travel and other perks, according to data culled from 12 drug companies and provided by the nonprofit investigative news organization ProPublica.

Dozens of these medical professionals were paid more than $100,000 each during that period. And 114 were professors, physicians, psychiatrists or researchers who were already paid a salary by the state — in some cases more than a half-million dollars a year. These state employees brought in nearly $3 million combined from pharmaceutical companies from 2009 to early 2011, according to a Texas Tribune analysis of the ProPublica data.

Nationwide, pharmaceutical manufacturers routinely pay medical professionals to assess a new product or to help contribute to the drug company’s sales. The companies fly medical professionals to seminars and conferences and may also pay speaking fees. State-employed doctors and researchers are generally no exception, though they are supposed to comply with their individual institutions’ conflict-of-interest policies.

“It’s important to state out of the gate the importance of these interactions, the value they bring to physicians, to health care professionals in general and ultimately to patients,” said Karl Uhlendorf, vice president of Pharmaceutical Research and Manufacturers of America.

But the financial relationships raise questions about the influence of drug companies on prescribing patterns or research results. The practice “puts patients and tax dollars at risk,” said Lee Spiller, the policy director for the Texas branch of the Citizens Commission on Human Rights, a nonprofit mental health watchdog. “It taints the whole process. I’d hate to think donations were shaping state mental health policy in particular.”

Dr. Stanley Self, a part-time psychiatrist at Texas’ state-run Rusk psychiatric hospital, earns $166,000 a year from the state. He also earned at least $145,000 from drug companies in 2009-10, largely for speaking engagements. Dr. Self did not return calls seeking comment on his work for drug companies, but his receptionist said he is “not doing much of that anymore.”

Christine Mann, a spokeswoman for the Department of State Health Services, said agency employees, like Dr. Self, are allowed to hold a second job as long as there is not a conflict of interest. The agency “is looking into this issue further and will examine its policies to see if there are provisions that need to be strengthened,” Ms. Mann said.

Dr. Joseph Bailes, an oncologist and the vice chairman of the executive committee at the Cancer Research and Prevention Institute of Texas, earned roughly $250,000 between 2009 and 2010 as a consultant for Pfizer. Dr. Bailes said that he has advised Pfizer on Medicare policy — not on drug development — and that it has no bearing on his role with the institute, a $3 billion endeavor financed by voter-approved bonds, for which he is an “unpaid volunteer” specializing in efforts to bring new cancer therapies to market.

“It doesn’t influence anything I do,” Dr. Bailes said, adding that his committee is not responsible for selecting projects for financing.

Dr. Stanley Lemon, who left his post as the director of the Institute for Human Infections and Immunity at the University of Texas Medical Branch in April and is now at the University of North Carolina, made nearly $80,000 consulting for Pfizer in 2009-10. Dr. Lemon, who is still an adjunct professor at U.T.M.B. but is no longer on the state payroll, said consulting for the pharmaceutical industry has enriched his academic life and made him a more productive scientist.

“As long as they are properly reported and do not engender conflicts of interest or commitment, such interactions between industry and academia help to move drug development forward in a positive way,” Dr. Lemon wrote in an e-mail.

The analysis of Texas pharmaceutical payments comes as the state attorney general’s office prepares for a mammoth trial in January against Janssen Pharmaceuticals and its parent company, Johnson & Johnson. Janssen, which has vigorously denied any wrongdoing, has been accused of offering trips and kickbacks to state health officials to get the schizophrenia drug Risperdal on an approved drug list for medications that are paid for by the state.

Across the country, the reporting of such perceived conflicts has traditionally fallen short. Companies have not been required to disclose payments, and medical institutions have made limited efforts to police their employees.

The ProPublica data covers just a part of drug company payments — it represents about 40 percent of the 2010 pharmaceutical market in the United States — and includes manufacturers that have either begun disclosing their payments voluntarily, or as a result of legal settlements.

Beginning in March, federal law will require drug and device companies to report and disclose all of their payments to medical professionals and researchers; by September, the data is supposed to be displayed in a searchable online government database. Texas universities — whose doctors and researchers account for $2.7 million of the pharmaceutical money statewide from 2009 to early 2011 — are working to update their own conflict policies and monitoring systems.

The University of Texas System will require its faculty members to report every dollar they are paid by a drug or device manufacturer and all financial interests in their research beginning Jan. 1.

The U.T. Southwestern Medical Center in Dallas is working on an electronic conflict-of-interest filing system that will feed into a soon-to-be-released public disclosure Web site, said Tim Doke, U.T.-Southwestern’s vice president for communications.

“We’ve been working feverishly here for the last couple of months,” Mr. Doke said. “Transparency is the absolute key to the public being confident that conflicts that exist are being managed appropriately.”

At the University of Texas MD Anderson Cancer Center in Houston, university administrators monitor drug company databases to ensure that faculty-conflict filings match, and to set limits on how much doctors and researchers can accept, said Dr. Raymond DuBois, the center’s provost and executive vice president.

But such efforts at transparency vary widely depending on the institution, or may be nonexistent when there is no institution at all. State records show that of the 74 doctors and psychiatrists statewide who have routinely prescribed the highest number of costly antipsychotic drugs to patients on Medicaid, the joint state-federal health insurance program for the disabled, children and the very poor, 10 received payments from drug companies in 2009-11 — from $11,000 to $180,000 each.

All but one got the payments from the maker of the drug they most commonly prescribed.

http://www.nytimes.com/2011/11/25/us/payments-to-doctors-by-pharmaceutical-companies-raise-issues-of-conflicts.html?_r=1

« Return to news items


Share

Israel Health Ministry: Use of ADHD drugs soars by 76% in 2010

Tuesday, November 22nd, 2011

Ministry figures recently passed on to Citizens Commission on Human Rights, a psychiatric and human rights violations watchdog, show 621 kilograms of methylphenidate were issued in 2010, compared with 352 kilograms in 2009.

The 2010 figures show the steepest increase since surveillance on Ritalin and Concerta marketing in Israel began in 1993. The surveillance is required since these drugs contain the active ingredient methylphenidate, which is classified in Israel as a dangerous drug.

Ritalin, a central nervous system stimulant that affects chemicals in the brain and nerves, is used to treat attention deficit disorder (ADD ) and attention deficit hyperactivity disorder (ADHD ). Ritalin is also used in the treatment of a sleep disorder called narcolepsy (an uncontrollable desire to sleep ).

Ministry figures recently passed on to Citizens Commission on Human Rights, a psychiatric and human rights violations watchdog, show 621 kilograms of methylphenidate were issued in 2010, compared with 352 kilograms in 2009.

http://www.haaretz.com/print-edition/news/israel-health-ministry-use-of-adhd-drugs-soars-by-76-in-2010-1.396957

« Return to news items


Share

Nazi Eugenics Employed — in North Carolina

Thursday, November 10th, 2011

“Between 1929 and 1974, the state – through its North Carolina Eugenics Board – authorized sterilizations of about 7,600 North Carolina residents classified as mentally ill, epileptic or “feeble-minded,” which generally meant an IQ of less than 70, the Observer said.“  — North Carolina Observer, November 10, 2011  (read the rest of the article below our note)

Note from CCHR on Eugenics:  In 1869,  English psychologist Francis Galton created the word “eugenics” from the Greek word, eugenes, meaning “good stock.”  He encouraged using “better” human stock from which to breed, and discouraged what he considered “less desirable” stock from having children, evidently considering himself part of the “better” stock and thereby capable of judging the future for all humanity. In 1870, British psychologist Herbert Spencer claimed that selective breeding of the fittest would bring about a superior race, while the unfit should be allowed to die out.  These notions of cultural hierarchy caught on in the United States and by the 1920s, eugenics sterilization was practiced in two-dozen states, with California accounting for more than half of the 16,000 operations performed between 1907 and 1933.  Beyond that, they formed the basis of much of Hitler’s Mein Kampf and the Holocaust that followed.

Nazi psychiatrist Ernst Rudin

In 1933 psychiatrist Ernst Rudin was chosen by Hitler’s Reich Ministry to lead Germany’s racial purity program. Rudin wasted no time in drafting the Nazi Sterilization Law which originally called for the sterilization of “schizophrenics,” “alcoholics,” and “manic-depressives” — the subjects of Rudin’s “research.” As these legal sterilizations began, programs were already underway to sterilize “black” Germans. The sterilization program expanded to include Jews, Gypsies and, in the words of Rudin, other “inferior race types.”  By the end of World War II, two million had been sterilized.  The majority of those sterilized were between the ages of twenty and forty.

Ernst Rudin praised Hitler and the Nazis for their “decisive… path-breaking step toward making racial hygiene a fact among the German people… and inhibiting the propagation of the congenitally (hereditarily) ill and inferior.”  He stated, “Only through the Fuhrer did our dream of over thirty years, that of applying racial hygiene to society, become a reality.”

 

The Post Chronicle – November 9, 2011

Force Sterilization Victims Speak Out

North Carolina officials report they have located only 41 survivors of thousands of state residents forced to undergo sterilization.

The Charlotte Observer reports state officials have spent more than a year trying to find those who had been sterilized so they can be compensated, because the operations were medically unnecessary and immoral.

Between 1929 and 1974, the state – through its N.C. Eugenics Board – authorized sterilizations of about 7,600 North Carolina residents classified as mentally ill, epileptic or “feeble-minded,” which generally meant an IQ of less than 70, the Observer said.

The newspaper said Wallace Kuralt, the head of the Mecklenburg County Welfare Department from 1945 to 1972, had a nationwide reputation as a leader in eugenic sterilization. In his words, his department sought clients from among “low mentality-low income families which tend to produce the largest number of children.”

He considered sterilization part of progressive family planning.

Some women came to the state pleading to be sterilized, particularly before the birth control pill. But Mecklenburg County advocated the operations for people who were poor, disabled or in trouble, the Observer said.

Most of the sterilizations occurred in the 1950s and early 1960s.

Today, parents can ask a judge to have a child sterilized but only as a last resort.

Ellen Russell, director of advocacy for The Arc of North Carolina, a non-profit that works with developmentally and intellectually disabled people, says IQ is not a dependable measure of someone’s ability to raise children.

“There are certainly people with developmental disabilities who can raise children well,” Russell said. “As there are people without developmental disabilities who can’t.”

In June of this year, officials heard gut-wrenching testimony from men and women sterilized by the state during a 50-year period to cut welfare costs.

The stories of about a dozen of the nearly 7,600 people who were sterilized at the direction of the state were heard during testimony before a state task force that will recommend ways to compensate them, The (Raleigh) News and Observer reported.

From the 1920s to the 1970s, the state-funded Eugenics Board determined certain groups of people – the poor, undereducated or mentally unstable – were unfit for parenthood. Former Gov. Mike Easley apologized to the state’s eugenics victims in 2002, but there has been no compensation so far.

Gov. Bev Perdue and four state representatives attended the session, thanking the victims for sharing their stories, but made no promises of compensation.

“I came here as a woman, a mama, a grandmama, and a governor of the state to say that it was wrong,” Perdue said. “I’m here to tell you how important these hearings are.”

One woman, Elaine Riddick, 57, told the panel she became pregnant when she was raped at age 14, CBS News reported. The day she delivered her son, doctors sterilized her on orders from the state.

“They said that I was feeble-minded, they said that I was promiscuous,” Riddick told CBS News. “I’ve always been able to take care of myself – I’ve never been promiscuous. So how can people use these things to describe a child that had been abandoned? Or that had been raped by the neighbor and then again, raped by the state of North Carolina?”

North Carolina state Rep. Larry Womble, a Democrat sitting on the task force, said he hoped lawmakers would pass legislation that would allow eugenics victims to receive compensation, as well as counseling and medical help.

CBS News said more than 60,000 people in 32 states were affected by state-sanctioned sterilization programs aimed at cutting welfare costs.

“The people who were the focus of this movement were the dispossessed of society,” Paul Lombardo, of Georgia State University’s College of Law, said. “In some cases, simply people of color.”

http://www.postchronicle.com/news/health/article_212389314.shtml

« Return to news items


Share

New Study Confirms: Millions of kids misdiagnosed with ADHD and drugged

Tuesday, September 20th, 2011

September 20, 2011

New Study published in American Journal of Family Therapy confirms millions of normal kids misdiagnosed with ADHD & drugged.

by CCHR Int—A new study published today in the American Journal of Family Therapy has found that millions of children have been misdiagnosed with Attention Deficit Hyperactivity Disorder (ADHD) and wrongly prescribed amphetamine-like drugs categorized by  the U.S. Drug Enforcement Administration (DEA) in the same class of highly addictive drugs as cocaine, opium and morphine.

The study conducted by researchers at the New England Center for Pediatric Psychology and the Rhode Island College Department of Special Education found that of the “over 5 million children who are now being treated with ADHD medication, a majority may be suffering from Faux-ADHD, a disorder linked to irregular bedtimes” and that a majority of the children diagnosed ADHD may be unnecessarily medicated.    Now while we at CCHR applaud any study on the issue of “ADHD” which is not  ghost written by Big Pharma or those with a vested interest in drugging kids, we would like to pose two simple questions regarding this latest study:

1)  If there is such as thing as  “Faux-ADHD” what exactly is “real” ADHD?    There are no blood tests, brain scans, x-rays or genetic abnormalities that can prove any child has a “real” condition of ADHD.   Therefore any diagnoses of ADHD is “Faux.”   The criteria for an ADHD diagnoses  rests entirely on a checklist of behaviors,  including such “abnormal” child behavior as:

  • “runs about or climbs excessively in situations when it is not appropriate”
  • ” is often “on the go”
  • “acts as if driven by a motor”
  •  ”blurts out answers”
  •  ”is easily distracted”
  • ” loses pencils or toys”
  • “often doesn’t seem to listen”

2)  Given the diagnoses itself is not a medical condition, what child being prescribed drugs isn’t being “unnecessarily medicated?”   ADHD drugs are classified by the DEA as schedule ll drugs because they are as highly addictive as cocaine, morphine and opium.  ADHD drugs such as Ritalin, Concerta and Adderall are documented by the FDA and international drug regulatory agencies to cause hallucinations, mania, psychosis, drug dependence,  stunted growth, insomnia,  heart attack, suicidal ideation and sudden death.  Normal children are simply being drugged.  Not medicated.  Drugged.

The fact is that any child diagnosed with ADHD has been misdiagnosed.  Any child placed on cocaine–like ADHD drugs is being unnecessarily drugged.  The diagnoses of ADHD in any circumstances is a Faux-diagnoses, serving only the psychiatric pharmaceutical industries and fueling their $4.8 billion a year ADHD drug empire.

 

« Return to news items


Share

Mental health services have become increasingly dominated by psychiatry’s ”medical model”

Friday, September 16th, 2011

The Sydney Morning Herald, Australia – “With More Talk in Mind” – Sep 15, 2011

by Dr. John Reed, Professor of Clinical Psychology

SERIOUS problems in Victoria’s mental health system have been revealed recently in The Age. The important thing now is to find solutions. In doing so we should remember that although Victoria is in the spotlight, similar ”crises” occur regularly all over the world. Perhaps this is because Victoria is not alone in having a system based on fundamentally flawed principles.

Mental health services have become increasingly dominated by psychiatry’s ”medical model”, which claims that feeling depressed, anxious or paranoid is primarily caused by genetic predispositions and chemical imbalances.

This has led to alarming rises in chemical solutions to distress. In New Zealand, one in nine adults (and one in five women) is prescribed antidepressants every year.

The public, however, in every country studied, including Australia, believes that mental health problems are caused by issues such as stress, poverty and isolation. The public also prefers talking therapies to drugs and electroconvulsive therapy (ECT).

Research suggests the public is right. For example, the single best predictor of just about every mental health problem is poverty, followed by other social factors such as abuse, neglect and early loss of parents in childhood, and – once in adulthood – loneliness and a range of adverse events including losses and defeats of various kinds.

Meanwhile, reviews of studies on anti-depressants (which only recently have been able to include those previously kept secret by drug companies) conclude that they are superior to placebos only for those at the extreme end of the ”most severe” group of depressed people. This represents less than 10 per cent of the people who are receiving these drugs.

A recent Cochrane review (the type most highly regarded in the scientific community) for risperidone, a leading anti-psychotic drug, ”suggests that there is no clear difference between risperidone and [a] placebo”.

A placebo (from the Latin meaning ”I please”) is not necessarily a bad thing. Indeed the talking therapies are effective partly because, if done well, they too instil hope and expectations of recovery.

The problem is that psychiatric drugs often have serious adverse effects. Anti-psychotics, for instance, can cause rapid weight gain, loss of sexual function, diabetes, heart disease, neurodegeneration and reduced life span.

As previously reported, my review of ECT studies (with Professor Richard Bentall of Liverpool University) found that this treatment is ineffective for most recipients and frequently causes permanent memory loss. This in itself can be depressing.

ECT also has a slight but significant risk of death, most frequently from cardiovascular failure.

Inpatient units are equally ineffective and can also be damaging. When will we learn that putting large numbers of extremely distressed people in the same building is not a good idea?

What I conclude from all this is that any review of mental health services in Victoria, or anywhere else for that matter, should probably be led by anyone other than a psychiatrist – and certainly not in Victoria’s case the state’s Chief Psychiatrist, whose job, according to Dr Ruth Vine herself, is “to watch over how the system is functioning”.

It is unfair to expect Dr Vine to take an objective view on the failure of the system for which she is responsible. That lack of objectivity is amply demonstrated by her claims that ECT is “safe and effective” and that the problem is the public’s “negative” views.

Perhaps a lawyer from the Mental Health Legal Centre might be a good choice.

Read the rest of the article here: http://www.smh.com.au/opinion/society-and-culture/with-more-talk-in-mind-20110914-1k9m2.html#ixzz1Y8tVJQlv

 

« Return to news items


Share

Psycho/Pharma’s Next Target? Shy Kids

Thursday, September 15th, 2011

The Daily Telegraph – September 15, 2011

by Emily Allen

Common problems among children such as shyness could be regarded as a mental illness

Children who are shy or considered moody run the risk of being diagnosed with mental illnesses and given powerful drugs like Prozac, psychologists have warned.

  • Experts fear widespread use of powerful medications
  • Hyperactive children already being treated with drugs
Experts said mental health diagnoses are likely to increase from 2013 as new guidelines on the definition of mental illness are being drawn up in America and are likely to be replicated in Britain.

Psychologists in the UK fear school-age children could be diagnosed with mental illnesses like ‘social anxiety disorder’ if they are quieter among their peers, or depression if a child is temporarily sad or is battling bereavement.

Meanwhile, youngsters who appear to lose their temper easily or answer back to adults could be classed as having ‘oppositional defiant disorder’.

Once diagnosed, psychologists say children are likely to be treated with powerful drugs like Prozac or Ritalin to curb their behaviour – without fully understanding the long-term impacts.

Ritalin is already used to help control attention deficit hyperactivity disorder in youngsters under six and about 650,000 children aged between eight and 13 have also been prescribed the drug or an equivalent.

Kate Fallon, general secretary of the Association of Educational Psychologists, told The Daily Telegraph: ‘Behaviours develop over a long period of time, often with a range of complex causes; we can’t “cure” the behaviours we don’t like with a quick fix of medicine.

‘They usually require careful management by all the adults around the child.’

She said parents need to take time and energy to help their children deal with their problems and warned it was tempting to opt for a drug which would be quick to change their behaviour.

The British Psychological Society is also concerned about the new guidelines and said pigeon-holing problems as ‘illnesses’ ignores the wider causes.

Read more: http://www.dailymail.co.uk/health/article-2037610/Children-pumped-powerful-drugs-combat-shyness-psychologists-warn.html#ixzz1Y3ZbweW8

For more information – Watch this:

Click to watch video, Psychiatry Labeling Kids with Bogus Mental Disorders

 

« Return to news items


Share

CCHR exposes list of psycho-pharma front groups

Monday, August 29th, 2011

Natural News
By PF Louis
August 29, 2011

A highly effective public relations technique is the “third party technique” of creating front groups to endorse or promote the need of any service or product. The first party is the original group or client that would benefit more from increased public trust or affinity. The second group is the public or consumers. A third group is created with a contrived name to appear publicly as a disinterested party endorsing the industry of the first party.

Often, the third party, or front group, uses a name that implies authority or concern for the public’s welfare or concerns. You can be sure these bogus front groups are usually only concerned about their clients welfare and themselves.

Edward Bernays Pioneered Front Groups

Edward Bernays, a notorious spin doctor throughout the 20th Century, is considered USA’s original front group creator as well as the father of public relations. The public relations industry is concerned with creating a favorable image more than direct sales advertising, although they can be closely associated at times.

The womens rights movement peaked in 1919 with the passage of the 19th amendment, granting women the right to vote. A very few years later, Edward Bernays created an image to help promote the tobacco industry. He had photographs published in newspapers and magazines of several women marching in a New York City Easter parade brazenly smoking cigarettes, which until then was considered unladylike. The idea was to link a womans struggle for more rights with openly smoking anywhere, just like the guys.

Besides making tobacco appear healthy over several years using fake doctors to promote various cigarette brands, Bernays also used front groups to glorify fluoridating water supplies. He was a very important contributor to our mass poisoning.

Psychiatry, Big Pharma, and Front Groups

The Citizens Commission on Human Rights International (CCHRI) focuses on psychiatry’s irrational and barbaric treatment of mental illness with its propensity for categorizing behavior in order to dispense harmful drugs. It’s a cozy arrangement with the American Psychiatric Association (APA) and Big Pharma.

Ever since the APA was accepted as a regular medical organization a few decades ago, Big Pharma’s sales for psychotropic drugs have gone through the roof. What was once pen and pad for taking notes by a psychiatrist during talk therapy became the pen and prescription pad.

For children, psychiatry’s categorizing behavioral problems enables educational and child care institutional personnel virtual prescription power as well. Children are kidnapped “legally” by social services agencies if parents refuse to medicate them according to psychiatric decree. Big Pharma’s reach into TV advertising enables depressed adults to demand prescriptions for drugs that lead to bad health, actual insanity, and death.

Front groups exposed by CCHRI include the following: The National Alliance on Mental Illness (NAMI), Children and Adults with Attention Deficit Hyperactivity Disorder (CHAAD) and several bipolar, depression or ADHD “support groups” that flourish on the internet.

CCHRI has several more front groups listed on one of their site pages with links to explanations of who they really are and how they function for psychiatry and Big Pharma. (see CCHRI source below)

CCHRI’s depth of investigative reporting offers the premier site for understanding the true nature of psychiatry and its relationship with Big Pharma’s destructive psychotropic drug racket.

Front Groups Everywhere

Front groups can also lobby directly to government officials, elected or appointed. And they are created for almost any controversial issue that needs to be white or green washed.

A former health insurance insider, Wendell Potter, became a whistle blower with his book Deadly Spin. He explained that a front group “Health Care America” was used to attack Michael Moore’s “Sicko” documentary.

APCO Worldwide created Health Care America with Big Pharma money. The insurance industry used APCO in 2007. APCO recruits think tanks and other agencies as allies for their campaigns. The public is unaware of who is really supplying the media’s information.

Earlier in 2011, New York Republican Congresswoman Nan Hayworth submitted a press release photo of her receiving a plaque from a representative of a purported senior citizen support group called 60 Plus Association. The sign above those two declared in large letters “Senor Citizens Thank You for Protecting Medicare and Social Security.”

There are two lies here. Nan Hayworth had voted against Medicare, and 60 Plus has hardly any senior citizen members at all. They remain afloat financially from Big Pharma’s funding, according to AARP.

All this crassly corrupt activity backed by government and corporations continues to escalate through the mainstream media. A lyric from a 1980s jazz tune rings true “We are Caught in a Blizzard of Lies.” The upside is we are forced to distinguish between truth and fiction and become our own informed authority.

Sources for this article include:

List of Front Groups for Psychiatry and Big Pharma http://www.cchrint.org/psycho-pharm…

Main page CCHRI site http://www.cchrint.org/

Insurance whistle blower Wendell Potter http://www.commondreams.org/view/20…

60s Plus Group outed by AARP as Big Pharma front group http://my.firedoglake.com/junkyardd…

Edward Bernays pioneered third party technique of PR and advertising http://www.frontgroups.org/node/418

« Return to news items


Share